Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | AMGN | BMY | GILD | VRTX |
| Company | Clovis Oncology Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.0808 | 265.72 | 44.68 | 65.50 | 393.52 |
| High | 0.0977 | 271.68 | 45.37 | 66.35 | 399.68 |
| Low | 0.0766 | 265.72 | 44.34 | 64.63 | 393.49 |
| Last | 0.0812 | 270.38 | 45.15 | 65.57 | 398.77 |
| Change | -0.0048 | +1.00 | +0.45 | +0.30 | +1.07 |
| % Change | -5.58% | +0.37% | +1.01% | +0.46% | +0.27% |
| Volume | 24,516,400 | 673,607 | 9,044,773 | 7,054,659 | 249,662 |
| 20-Day Average Volume | 9,433,500 | 2,066,926 | 12,582,585 | 6,773,638 | 921,673 |
| Previous Close | 0.0860 | 269.38 | 44.70 | 65.27 | 397.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 269.99 | 49.48 | 68.30 | 401.37 |
| 20-Day Raw Stochastic | 1.73% | 40.81% | 7.68% | 9.84% | 27.33% |
| 20-Day Relative Strength | 23.83% | 45.67% | 30.50% | 29.53% | 44.17% |
| Weighted Alpha | -91.19 | +9.55 | -33.91 | -23.40 | +15.52 |
| Today's Opinion | 100% Sell | 56% Sell | 88% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 88% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 8% Buy | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | +0.46% since 04/19/24 | -7.83% since 04/19/24 | -1.92% since 04/19/24 | +1.28% since 04/19/24 |
| Low | 0.0760 on 12/16/22 | 265.72 on 04/26/24 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 393.00 on 04/25/24 |
| High | 0.1439 on 12/14/22 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | -4.12% since 03/26/24 | -14.18% since 03/26/24 | -9.58% since 03/26/24 | -4.57% since 03/26/24 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 |
| High | 0.3772 on 12/01/22 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | -13.35% since 01/26/24 | -9.26% since 01/26/24 | -17.66% since 01/26/24 | -7.17% since 01/26/24 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 |
| High | 1.3100 on 10/04/22 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 80.00 on 01/29/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | +0.17% since 10/26/23 | -14.86% since 10/26/23 | -16.59% since 10/26/23 | +10.53% since 10/26/23 |
| Low | 0.0760 on 12/16/22 | 249.70 on 10/31/23 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 341.90 on 11/16/23 |
| High | 3.2500 on 07/08/22 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 144,488,960 | 90,596,128 | 81,266,176 | 102,789,152 |
| Shares Outstanding, K | 144,955 | 536,376 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 148,760,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -264,520,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 30,660,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -56,010,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 0.24 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | 4.71 on 02/06/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 11/09/22 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 6.51 | 9.98 | 29.82 |